Alexis, A.; Anders, K.; Seetasith, A.; Holden, M. Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria. J of Skin 2023, 7, s299.